Calithera Biosciences (STU:2CB0) Total Equity : €19.25 Mil (As of Dec. 2022)

View and export this data going back to 2014. Start your Free Trial

What is Calithera Biosciences Total Equity?

Calithera Biosciences's total equity for the quarter that ended in Dec. 2022 was €19.25 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Calithera Biosciences Total Equity Historical Data

The historical data trend for Calithera Biosciences's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Calithera Biosciences Total Equity Chart

Calithera Biosciences Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Total Equity

Get a 7-Day Free Trial

111.38

128.18

84.15

7.42

19.25

Calithera Biosciences Quarterly Data
	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22
Total Equity	Get a 7-Day Free Trial															7.42	-2.85	33.35	26.65	19.25

Calithera Biosciences Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Calithera Biosciences's Total Equity for the fiscal year that ended in Dec. 2022 is calculated as

Total Equity	=	Total Assets(Q: Dec. 2022 )	-	Total Liabilities(Q: Dec. 2022 )
	=	27.07	-	7.82
	=	19.25

Calithera Biosciences's Total Equity for the quarter that ended in Dec. 2022 is calculated as

Total Equity	=	Total Assets(Q: Dec. 2022 )	-	Total Liabilities(Q: Dec. 2022 )
	=	27.07	-	7.82
	=	19.25

Calithera Biosciences Total Equity Related Terms

Thank you for viewing the detailed overview of Calithera Biosciences's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Calithera Biosciences (STU:2CB0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Calithera Biosciences Inc (STU:2CB0) » Definitions » Total Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

343 Oyster Point Boulevard, Suite 200, South San Francisco, CA, USA, 94080

Website

https://www.calithera.com

Calithera Biosciences Inc is a clinical-stage pharmaceutical company. The business activity of the firm functions through the region of the United States. It focuses on discovering and developing small molecule drugs directed against tumor and immune cell targets that control key metabolic pathways in the tumor microenvironment. Its product candidate is CB-839, an inhibitor of glutaminase for the treatment of solid tumors. Its other product candidate, CB-1158, is being developed for hematology and oncology indications.

Calithera Biosciences (STU:2CB0) Headlines

No Headlines